INNT
TOTAL INVALIDATION PROCESSED BY THE IB
04/19/2025
Back to search
Official data from USPTO
BICYCLE DRUG CONJUGATE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
BICYCLE DRUG CONJUGATE
ST13
US500000079189674Class
5, 42
Filing
79189674
Registration
5314176
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
41
Latest update
05/14/2025
Trademark type
Word
Nice classes
5, 42
Filing date
04/06/2016
Registration date
10/24/2017
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/10/2024
Last transaction
05/14/2025
Responsible office
United States Patent and Trademark Office
Status code
709
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
GB
Examiner
BIBB, SCOTT
Law office
L90
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Bicycletx Limited
Bicycle Therapeutics Limited
Representatives
Jacqueline P. Scheib Robinson & Cole LLP
Technical classification
Nice Classes
Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical productspharmaceutical preparations for use in oncology for both solid and liquid tumorsmetabolic diseaseurology and renal diseasecardiovascularhematologyrespiratorychronic and acute inflammatory disease and auto-immune disordersgastrointestinal diseasebacterial and viral infectious diseaseneurological and psychiatric disorders; pharmaceutical preparations for use as diagnostics and clinical imaging agents
Class 42
Scientific and technological servicesnamely scientific research in the field of human and veterinary disease; diagnosis of diseasenamely scientific study and research in the field of the development of future human and veterinary medical treatments in the field of oncology for both solid and liquid tumorsmetabolic diseaseurology and renal diseasecardiovascularhematologyrespiratorychronic and acute inflammatory disease and auto-immune disordersgastrointestinal diseasebacterial and viral infectious diseaseneurological and psychiatric disordersdiagnostics and clinical imaging agents; industrial analysis and research services in the field of oncology for both solid and liquid tumorsmetabolic diseaseurology and renal diseasecardiovascularhematologyrespiratorychronic and acute inflammatory disease and auto-immune disordersgastrointestinal diseasebacterial and viral infectious diseaseneurological and psychiatric disordersdiagnostic preparations and clinical imaging agents; providing informationconsultancy and advisory services relating to the designplanning and implementation of scientific and clinical research for othersnamely designplanning and implementation project management of scientific research and clinical trials
Publications
History of USPTO decisions and trademark events.
41 publications found
INTS
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
03/27/2025
INPC
INVALIDATION PROCESSED
03/27/2025
INTR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
01/11/2025
C71T
CANCELLED SECTION 71
05/10/2024
NREP
NEW REPRESENTATIVE AT IB RECEIVED
12/01/2023
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
10/24/2022
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
09/24/2022
NREP
NEW REPRESENTATIVE AT IB RECEIVED
09/17/2021
CHLD
CHANGE OF OWNER RECEIVED FROM IB
03/21/2019
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
03/16/2018
FICS
FINAL DISPOSITION NOTICE SENT TO IB
01/30/2018
FIMP
FINAL DISPOSITION PROCESSED
01/30/2018
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
01/24/2018
R.PR
REGISTERED-PRINCIPAL REGISTER
10/24/2017
GPNX
NOTIFICATION PROCESSED BY IB
08/18/2017
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
08/08/2017
PUBO
PUBLISHED FOR OPPOSITION
08/08/2017
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
08/02/2017
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
08/02/2017
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
07/19/2017
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/29/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/29/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/28/2017
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
06/28/2017
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
06/28/2017
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
06/28/2017
CNFR
FINAL REFUSAL MAILED
04/17/2017
CNFR
FINAL REFUSAL WRITTEN
04/14/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/03/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/02/2017
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/02/2017
RFNT
REFUSAL PROCESSED BY IB
09/09/2016
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
08/25/2016
RFRR
REFUSAL PROCESSED BY MPU
08/25/2016
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
08/23/2016
CNRT
NON-FINAL ACTION WRITTEN
08/22/2016
MAFR
APPLICATION FILING RECEIPT MAILED
08/09/2016
DOCK
ASSIGNED TO EXAMINER
08/05/2016
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/05/2016
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
08/04/2016
Continuous trademark protection
Get notified about every new filing that threatens BICYCLE DRUG CONJUGATE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.